| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks
1 company
Anders Jack is a Chief Financial Officer at Revolution Medicines, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $19.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 2,244 | $44.19 | $99,151.81 | -2.2% | +0.4% | +0.4% | |
| Jun 17, 2024 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 1,893 | $37.39 | $70,774.73 | -1.8% | +20.1% | +5.5% | |
| May 3, 2024 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sale+OE | 10,000 | $40.03 | $400,260.00 | -8.9% | +12.6% | +1.3% | |
| Mar 18, 2024 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 1,261 | $31.58 | $39,826.42 | -1.2% | +19.9% | +23.3% | |
| Dec 18, 2023 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 1,775 | $25.90 | $45,975.70 | -2.3% | +17.5% | +71.5% | |
| Sep 18, 2023 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 1,427 | $31.31 | $44,680.23 | -2.6% | -14.9% | +41.5% | |
| Sep 1, 2023 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sale+OE | 20,000 | $35.05 | $701,092.00 | -26.6% | -33.4% | +21.6% | |
| Jun 20, 2023 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 1,249 | $24.89 | $31,088.86 | -2.2% | +20.4% | +46.2% | |
| Mar 17, 2023 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 665 | $21.78 | $14,483.70 | -1.2% | +16.0% | +46.9% | |
| Dec 19, 2022 | RVMD Revolution Medicines, Inc. | Chief Financial Officer | Sell | 658 | $22.94 | $15,094.85 | -2.2% | -1.1% | +20.8% |